✦ LIBER ✦

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib

✍ Scribed by Hochhaus, A; Baccarani, M; Deininger, M; Apperley, J F; Lipton, J H; Goldberg, S L; Corm, S; Shah, N P; Cervantes, F; Silver, R T

Book ID: 109886827
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 191 KB
Volume: 22
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2008.84

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dasatinib induces significant hematologi

Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase

✍ Guilhot, F.; Apperley, J.; Kim, D.-W.; Bullorsky, E. O.; Baccarani, M.; Roboz, G 📂 Article 📅 2007 🏛 American Society of Hematology 🌐 English ⚖ 137 KB

Dasatinib induces complete hematologic a

Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis

✍ Cortes, J.; Rousselot, P.; Kim, D.-W.; Ritchie, E.; Hamerschlak, N.; Coutre, S.; 📂 Article 📅 2006 🏛 American Society of Hematology 🌐 English ⚖ 118 KB

Dasatinib: From Treatment of Imatinib-Re

Dasatinib: From Treatment of Imatinib-Resistant or -Intolerant Patients With Chronic Myeloid Leukemia to Treatment of Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

✍ Brian L. Abbott 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Dasatinib early intervention after cytog

Dasatinib early intervention after cytogenetic or hematologic resistance to imatinib in patients with chronic myeloid leukemia

✍ Alfonso Quintás-Cardama; Jorge E. Cortes; Susan O'Brien; Farhad Ravandi; Gautam 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 2 views

Efficacy and safety of dasatinib in imat

Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase

✍ Cortes, J; Kim, D-W; Raffoux, E; Martinelli, G; Ritchie, E; Roy, L; Coutre, S; C 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 148 KB

Comparing nilotinib with dasatinib as se

Comparing nilotinib with dasatinib as second-line therapies in patients with chronic myelogenous leukemia resistant or intolerant to imatinib – a retrospective chart review analysis

✍ Griffin, James D.; Guerin, Annie; Chen, Lei; Macalalad, Alexander R.; Luo, Jiayu 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 305 KB